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ABSTRACT
Blood glucose levels are regulated by the interactions between insulin and glucagon.
Pancreatic alpha cells release glucagon in response to a drop in blood sugar. Pancreatic alpha cells
appear to be regulated through multiple signaling pathways. One potential method of regulation
occurs from α-MSH or epinephrine stimulated production of the intracellular messenger cyclic
AMP. Exocytosis of dense core vesicles containing glucagon ultimately requires an increase in
cytosolic Ca2+. This study focused on the link between cyclic AMP and calcium in pancreatic alpha
cells which allows alpha cell regulation. Interactions between calcium and cyclic AMP in pancreatic
alpha cells consists of PKA-dependant and PKA-independent pathways. The results indicate cyclic
AMP pathways control L-type voltage-gated calcium channels and also increase cytoplasmic
calcium from intracellular stores. Store release appears to be through IP3 mediated pathways and not
through the ryanodine-sensitive receptor.
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Introduction
Regulation of blood glucose levels occurs from the secretory products from the islets
of Langerhans. When blood glucose levels rise β-cells release insulin to lower blood
sugar and when blood sugar drops too low, α-cells release glucagon in order to increase
plasma glucose levels. This regulation is essential and when problems occur within this
endocrine system, control of plasma glucose levels is jeopardized. Understanding the
mechanisms by which glucose is regulated provides insight about how to treat disruptions
in glucose homeostasis.
Composition and Structure of the Islets of Langerhans
The endocrine pancreas is composed of the islets of Langerhans within the pancreas
(Quesada et al, 2008). A healthy human pancreas contains approximately one million
islets, which constitutes one to two percent of the total mass of the pancreas (Quesada et
al, 2008). The size of individual islets varies from 100 to 500 microns and contains
approximately 1000 to 3000 cells (Quesada et al, 2008).
Within the islets of Langerhans five different cell types exist. In the human pancreas
insulin secreting β-cells compose 48 to 59 percent of the islets (Quesada et al, 2008),
glucagon secreting α-cells compose 33 to 46 percent (Quesada et al, 2008), somatostatin
secreting δ-cells less than 10 percent (Cabrera et al, 2006), pancreatic polypeptidesecreting cells 5 percent (Quesada et al, 2008), and ghrelin -producing cells have also
been observed (Quesada et al, 2008, Gromada et al, 2007,Cabrera et al, 2006). However,
the mouse and rat pancreas contain a higher percent of β-cells, which account for 60 to
1

80 percent, while α-cells account for 15 to 20 percent (Quesada et al, 2008; Rorsman et
al, 2008). In the majority of species, pancreatic polypeptide-secreting cells and
somatostatin cells are minority cell types, while β-cells are the most abundant (Cabrera et
al, 2006).
The actual structure of the islets of Langerhans differs across species. Human
pancreases have a random distribution pattern of cell types, where β-cells come into
contact with non β-cells (Quesada et al, 2008; Gromada et al, 2007). A difference exists
between islet organization in rodents and primates (Cabrera et al, 2006). Cross-sectional
studies show that mouse and rat islets are more organized than primate islets, where in
rodent islets the β-cells are located in the core of the islet and the α-cells, δ-cells, and
pancreatic polypeptide-secreting cells are dispersed around the mantle of the islet
(Quesada et al, 2008; Gromada et al, 2007; Cabrera et al, 2006). A random distribution
pattern in primates suggests possible paracrine interactions between different cell types
(Gromada et al, 2007). The organization of the islets facilitates paracrine regulation of
the α-cells by the β-cells (Rorsman et al, 2008).
Physiological Glucose Regulation
Blood glucose levels are regulated by the cellular secretions of insulin and
glucagon from the endocrine component of the pancreas, the islets of Langerhans
(Quesada et al, 2008; Quesada et al, 2006). Fasting plasma glucose levels range from
four to seven millimolar, and two hours after food intake, glucose levels should range
from eight to ten millimolar. As blood sugar increases, β-cells respond by secreting
insulin, which acts on muscle, liver and adipose tissue causing the tissues to incorporate
glucose in the form of glycogen and fat (Quesada et al, 2008; Quesada et al, 2006). α-
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Cells release glucagon in response to a drop in blood glucose, which initiates
glycogenolysis and gluconeogenesis leading to an increase in blood glucose (Quesada et
al, 2008; Rorsman et al, 2008; Quesada et al, 2006). Abnormal function of cells in the
islets leads to the development of diabetes from the loss of control of blood glucose
levels (Quesada et al, 2008). Having higher levels of glucagon compared to insulin
causes elevated levels of glucose output, leading to sustained hyperglycemia in diabetic
patients (Quesada et al, 2008). Little is understood about α-cells physiology in
comparison to β-cells physiology because the scarcity of the cells and the lack of
functional identification patterns (Quesada et al, 2008; Ravier et al, 2005). The
molecular regulation of α-cells remains scarcely understood (Ravier et al, 2005).
Physiological regulation of glucagon secretion from α-cells involves input from
paracrine, neuronal and intrinsic mechanisms (Rorsman et al, 2005, 2008). When nerves
have been severed, glucagon secretion can still be regulated, which suggests that neuronal
connections are not the only thing regulating α-cells (Rorsman et al, 2005, 2008).
Pancreatic α-cells contain channels that generate action potentials, or sense voltage
changes when glucose levels are low or absent (Quesada et al, 2008). Voltage-gated
sodium and calcium channels play a major role in creating these action potentials
(Quesada et al, 2008). Electrical activity controls Ca2+ influx and the Ca2+ signals that
control glucagon secretion (Quesada et al, 2008). Elevated levels of glucose seem to
inhibit the Ca2+ signals and glucagon secretion (Quesada et al, 2008). Glucagon should
not be secreted when plasma glucose levels are high, making this an important aspect of
regulation in α-cells. However, direct glucose effects would stimulate secretion in αcells through the ATP-dependant K+ (KATP) channel (Quesada et al, 2008). In humans
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and rodents paracrine signals from other islet cells have inhibitory action on glucagon
secretion. In addition, the presence of elevated glucose might directly suppress glucagon
secretion and lastly the hypothalamus might have control of secretion (MacDonald et al).

After Food…
High Blood Glucose

Insulin

β Cell

Store Glucose

Fasting…
Low Blood Glucose

?

Glucagon
α Cell

Release Stored
Glucose

Figure 1: Blood glucose regulation. Plasma glucose levels are primarily regulated
through the secretions from β-cells and α-cells. Signals that cause α-cells to secrete
glucagon still remain unknown.
ATP-Sensitive Potassium Channels
ATP-sensitive K+ channels are inhibited by an increase in intracellular ATP
concentrations (Ashcoroft et al, 2000). The KATP channels have a significant impact on
membrane potential and action potential (Quesada et al, 2008). The mechanism in αcells by which the KATP channel works is still in question. α-Cells possess the same type
of KATP channel as those that effect membrane potential in β-cells (Rorsman et al, 2008).
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It is unclear how KATP depolarization stimulates β-cells to release insulin, however it is
not known how KATP inhibits α-cells to release glucagon (MacDonald et al, 2007).
β-Cells have comparable densities of KATP channels as α-cells (Gromada et al,
2007), which allows for some comparison about how they function in the α-cells. In βcells, inhibition of the KATP channels leads to depolarization, which ultimately leads to
exocytosis of insulin (Ashcoroft et al, 2000). This channel is critical for glucose induced
insulin release (Béguin, 1999). At rest β-cells have a negative membrane potential,
around -70 mV (Gromada et al, 2007). In low levels of glucose KATP channels
spontaneously open in β-cells, leading positively charged potassium to leave the cell,
which creates a less negative membrane potential (Rorsman, 2003). Glucose enters βcells through the glut2 transporter, which leads to increased ATP production (Rorsman,
2003). As extracellular glucose levels rise, more glucose enters the cell leading to an
increase in production of ATP. This produces a concentration-dependent inhibition of
the KATP channel due to the changing concentrations of ATP and ADP (Gromada et al,
2007). Rising ATP inhibits the function of the KATP channel causing the channel to close
(Gromada et al, 2007; Ashcoroft et al, 2000). Closing of the KATP channel causes the
membrane to depolarize (Gromada et al, 2007). The change in membrane potential
activates the voltage-gated calcium channels, which causes the calcium channels to open
and allow calcium to enter the cell. Rising calcium levels generates calcium dependent
exocytosis of dense core vesicles containing insulin (Gromada et al, 2007; Ravier et al,
2005).
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Similarly in isolated rat α-cells high concentrations of glucose cause the KATP
channel to close and this ultimately leads to calcium influx and secretion (Quesada et al,
2008). It is paradoxical for α-cells release glucagon to increase glucose levels, when
glucose levels are already high. However, in vivo α-cells do not respond to high glucose
levels (Quesada et al, 2008). Bringing up the questions of why α-cells have the same
KATP channel as β-cells, and how are they regulated in α-cells, if α-cells are not supposed
to secrete glucagon in high levels of glucose (Rorsman et al, 2008; MacDonald et al,
2007).
One study showed that without the presence of β-cells, glucose caused a rise in
free cellular ATP concentrations in clonal mouse α-TC1-9 cells (Ravier et al, 2005)
causing the KATP channel to be blocked. Calcium oscillations were also inhibited by an
increase in glucose concentrations and insulin in α-TC1-9 (Ravier et al, 2005). In αcells lower levels of ATP are needed in order to have maximal inhibition of KATP
conductance than that required in β-cells (Quesada et al, 2008). Unlike β-cells,
physiologically α-cells should be activated in low plasma glucose concentrations, since
glucagon will raise plasma glucose levels. Sensitivity to KATP channels varies by
different tissues (Ashcoroft et al, 2000), which might partially explain this different
regulation in different cell types. Glucagon release most likely happens at relatively low
level of plasma glucose because of the intermediate activity of the KATP channel
(Quesada et al, 2008). Similar models of KATP function have been shown for human αcells (Quesada et al, 2008).
Several different models exist about glucagon secretion and α-cell depolarization.
One theory suggests that glucose is hyperpolarizing cells as opposed to depolarizing the
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cells (Quesada et al, 2008). Another theory suggests glucose is inhibiting glucagon
secretion by suppressing Ca2+ store-operated current independent of the KATP channel
(Quesada et al, 2008). α-Cells also differ from β-cells in that α-cells contain a large Na2+
current, which is essential for glucagon release (MacDonald et al, 2007). Finally, it seems
evident that there are signals coming from somewhere else that are causing inhibition of
secretion of α-cells. α-Cells appear to be highly sensitive to secretory products from βcells supporting the idea that paracrine effects control α-cells secretion of glucagon
(Gromada et al, 2007). This paracrine inhibition is regulated by insulin/Zn2+, GABA
from β-cells and somatostatin from δ-cells.
Calcium Channels and Function
Calcium increase in β-cells is linked to three types of channels (Chen et al, 2009).
The primary increase is due to influx through voltage-gated Ca2+ channels on the plasma
membrane. Ca2+ increase can be augmented by ER-store release through ryanodine
receptors and inosital 1,4,5-triphosphate receptors (IP3) (Chen et al, 2009). In α-cells
intracellular Ca2+ oscillations are interconnected to the electrical activity of the α-cell and
reflect glucagon release by glucose (MacDonald et al, 2007).
Voltage-dependent calcium channels present in all excitable cells regulate
calcium influx during membrane depolarization (Catterall et al, 2005). These channels
are transmembrane ion channels, composed of four or five distinct subunits (2000,
Catterall et al, 2005). The α1 subunit is the largest subunit, which incorporates the
voltage sensor, conduction pore, gating apparatus and the site of regulation to which
second messengers, drugs or toxins bind (2000; Catterall et al, 2005). Auxiliary subunits
modulate the properties of the channel; however, multiple forms of the α1 subunit create
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pharmacological and electrophysiological diversity in these complexes (Catterall et al,
2005). Four different subtypes of voltage-gated calcium channels have been reported in
α-cells (Quesada et al, 2008). It was reported that rat α-cells contain L- and N-type
calcium channels, while mouse α-cells contain L-, N-, T- and R-type Ca2+ channels
(Quesada et al, 2008). All of these channels are functionally different.
L-type Ca2+ channels require strong depolarization for activation and are longlasting (2000; Catterall et al, 2005). Typically L-type channels open during action
potentials when the membrane exceeds -40 to -30 mV, however some activate at lower
voltages, but these subtypes are predominately found in neurons and cardiac pacemaker
cells (Quesada et al, 2008). Under certain conditions, most of the Ca2+ currents in α-cells
are thought to go through L-type Ca2+ channels (Quesada et al, 2008). In the presence of
cyclic adenosine monophosphate (cAMP) L-type channels become major conductors of
the Ca2+ current in α-cells (Quesada et al, 2008).
N-type Ca2+ channels also require strong depolarization for activation and open
during action potentials when the membrane potential exceeds -40 to -30 mV (Catterall et
al, 2005, Quesada et al, 2008). These channels are sensitive to voltage-dependent
inactivation and at low levels of glucose; Ca2+ influx through the N-type channel
mediates exocytosis (Quesada et al, 2008). Mice lacking N-type Ca2+ channels show a
decreased level of plasma glucagon, suggesting that these channels play a role in glucose
regulation (Gromada et al, 2007).
T-type Ca2+ channels are activated by weak depolarizations and are transient
(Catterall et al, 2005). The channels are activated around -65 mV near threshold for
action potential generation and may play a role in action potential initiation (Gromada et
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al, 2007). Toxins and organic antagonists used to define N- and P/Q- type currents do not
have an effect on T-type Ca2+ currents (Catterall et al, 2005). These work as pacemakers
in initiation of action potentials and control repetitive firing (Quesada et al, 2008,
Catterall et al, 2005).
The final type of Ca2+ channel that has been reported in α-cells are the R-type
Ca2+ channels (Quesada et al, 2008; Gromada et al, 2007). These also require strong
depolarizations for activation (Catterall et al, 2005).
Pro-opiomelanocortin and Epinephrine
Pro-opiomelanocortin (POMC) is expressed in a variety of tissues including the
pituitary gland, skin, immune system and brain (Pritchard et al, 2002). Sequenced
mammalian POMC genes consists of three exons interspersed by introns (Millington,
2007). Post-translational processing by propeptide convertases, PC1 and PC2, leads to
eight biologically active peptides (Millington). The products include: adrenocorticotropic
hormone (ACTH), β-lipotropin (LPH), corticotrpin-like intermediate peptide (CLIP), γLPH, α-melanocyte stimulating hormone (MSH), β-endorphin, γ-MSH and β-MSH
(Millington, 2007, Pritchard et al, 2002). These peptides have important roles in skin,
stress response, immune system, sexual behaviors and feeding behaviors (Millington,
2007). The POMC peptide products show biological effects through melanocortin
recpectors (Pritchard et al, 2002).
Pro-opiomelanocortin (POMC) knockout mice lack important molecules in the
regulation of glucose homeostasis (Hochgeschwender et al, 2003). Glucose tolerance
tests POMC-null mice reacted similarly to the control wild-type mice. However, when
POMC-null mice were challenged to insulin tolerance tests, glucose levels continued to
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drop and eventually leading to death caused by hypoglycemic shock (Hochgeschwender
et al, 2003). When injected with α-MSH analog POMC-null mice were able to recover
from the insulin tolerance test (Hochgeschwender et al, 2003). This test indicates that
MSH plays an important role in α-cell signaling and glucagon secretion.
Five different melanocortin (MC) receptors have been described, (MC1R-MC5R)
(Cone, 2006). All five receptors are known to be G protein-coupled receptors (Rana,
2003) and interact with Gαs proteins, leading to stimulation of adenylate cyclase and an
increase in cAMP (Cone, 2006; Pritchard et al, 2002). cAMP is the main intracellular
signal generated by melanocortin receptors (Cone, 2006).
Glucagon secretion in α-cells can also be stimulated by epinephrine. Epinephrine
binds to β adrenergic receptors, which leads to activation of adenylate cyclase. Similarly
to MSH, the adrenergic pathway may play an important role in α-cell regulation via
stimulated production of cAMP.
Cyclic Adenosine Monophosphate
Stimulation of heterotrimeric G-protein-coupled receptors can activate adenylate
cyclase leading to an increase in cAMP (Bos et al, 2006; Ganong, 2005; Richards, 2001).
Phosphodiesterase metabolizes cAMP (Ganong, 2005). Cyclic AMP has several targets,
which lead to different reactions in cells (Walsh et al, 1994). This second messenger has
many different physiological roles, all of which were initially attributed to cAMP binding
to protein kinase A (PKA) leading to its activation (Kang et al, 2006; Bos et al, 2006).
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Two pathways exist for cAMP, PKA-dependent and PKA-independent pathways
(Gromada et al, 2007). Specific targets of cAMP include: cAMP binding to PKA,
cAMP-regulated ion channels and Epac (Exchange protein directly activated by cAMP)
(Bos et al, 2006).
Three factors play a role in the ability for cAMP to bind to proteins in a cell
(Walsh et al, 1994). Proteins are often anchored near kinases, where they are more likely
to be phosphorylated than interact with cAMP (Walsh et al, 1994). Protein structures
also play a role in the interaction between the protein and cAMP. Tertiary structures of
proteins and area surrounding the serine will influence the ability for the protein to be
phosphorylated and will affect its ability to interact with cAMP (Walsh et al, 1994).
Lastly, if proteins have allosteric interactions or covalent modifications this will influence
the ability to bind to cAMP (Walsh et al, 1994).
Protein Kinase A
cAMP activates Camp-dependent protein kinase (protein kinase A, PKA), which
has several functions (Ganong, 2005). PKA is composed of two catalytic subunits and
two regulatory subunits (Ponsioen et al, 2004). In order to activate PKA four molecules
of cAMP are required, each regulatory subunit will bind two molecules of cAMP. Upon
cAMP binding the regulatory subunits dissociate from the catalytic subunits and the
catalytic subunits become active (Ponsioen et al, 2004). Once active PKA catalyzes the
phosphorylation of proteins that cause conformational changes that lead to a change in
function (Ganong, 2005). The proteins that become phosphorylated largely depend on
subcellular localization (Walsh et al, 1994). PKA has been shown to activate pathways,
such as the mitogen-activated protein kinases in cell specific manners, cAMP regulatory
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element-binding protein and co-regulatory molecule CREB-binding proteins (Richards,
2001). Channel phosphorylation most often occurs with either PKA and protein kinase
C (Béguin, 1999). PKA phosphorylation of L-type Ca2+ channels is a recognized method
of regulation in many cell types (Kang et al, 2006). After being phosphorylated, the
kinetics of the channel changes or more channels become active in the plasma membrane
(Béguin, 1999). In β-cell lines KATP channels have been shown to be regulated by PKA
phosphorylation (Béguin, 1999). PKA has a wide variety of targets that have effects on
cellular responses.
Exchange Protein Activated by Cyclic AMP
Epac is a cAMP regulated guanine nucleotide exchange factor (Holz et al, 2004).
The hypothesized structure suggests the regulatory domains auto-inhibit binding of Rap
from binding due to steric hindrance (Ponsioen et al, 2004). At low levels of cAMP Epac
is folded, covering binding domains, which lead to its inactive state. Once cAMP binds
Epac unfolds, exposing the Rap binding site (Ponsioen et al, 2004). Two different forms
of Epac exist: Epac 1 and Epac 2, which are both present in the pancreas (Holz et al,
2004; Kang et al, 2006). (Note that in this research there will be no differentiation
between the two forms of Epac.) Cyclic AMP binding affinity for Epac is similar to the
binding affinity to PKA (Holz et al, 2004). Epac interacts with a variety of proteins.
Epac stimulates Rap 1 and Rap 2, hormone gene expression, phoshilpase C-epsilon,
integrin-mediated cell adhesion, cardiac gap junction formation, vascular endothelial cell
barrier formation and cell signaling (Holz et al, 2004). Evidence also suggests that Epac
might affect ion channels and exocytosis in excitable cells (Kang et al, 2006).
Interactions between Epac and a subunit of the KATP channel and secretory granule
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associated proteins may lead to exocytosis in excitable cells (Kang et al, 2006). Epac 1
and Epac 2 may both serve as accessory subunits of the KATP channel possibly with the
SUR1 subunit (Holz et al, 2006). Both Epac 1 and Epac 2 immunoprecipitate with the
KATP channel subunit SUR1, indicating an interaction (Kang et al, 2006; Holz et al,
2004). A β-cell model supports the idea that cAMP may be working through Epac in
order to regulate KATP channels (Kang et al, 2006). The use of Epac analogues led to
KATP channel inhibition in β-cells (Kang et al, 2006). Epac-mediated actions also
influence Na2+, K+, Ca2+, and Cl- channel functions (Holz et al, 2004).
Through its various effects within cells Epac may influence Ca2+ concentrations
(Holz et al, 2004). Epac-mediated actions help mobilize Ca2+ from intracellular stores
through either IP3 receptors or ryanodine receptors by opening the channels (Holz et al,
2006). Epac through Rap and ERK phosphorylation of channels increases sensitivity to
Ca2+ or Ca-mobilizing second messengers (Holz et al, 2004).

Figure Two: Cyclic AMP’s potential targets within α-cells. After formation of cAMP the
specific targets and functions are not understood.
13

Thesis objective
Stimulation of melanocortin or β-adrenergic receptors leads to an increase of the
second messenger cAMP in α-cells. The function of this second messenger on glucagon
secretion is still not understood. Since glucagon secretion is a Ca2+ dependent process
there might be a relationship linking cAMP and Ca2+ in α-cells. The studies conducted
for this thesis were aimed at determining this link and included assessment of PKAdependent and PKA-independent pathways and investigation of the various ion channels
involved.

14

Methods and Materials
Culturing α-cells
Two related clonal mouse alpha cell lines were used. αtc1-6 cells were provided
by Professor Donald Steiner from the University of Chicago and αtc1-9 cells were
obtained from the American Type Culture Collection. Cells were cultured in DMEM
glucose adjusted to 15 mM, 10% Heat Inactivated Fetal Bovine Serum, 1% 10X MEM,
1% Penicillin/Streptomyocin, 1%, Sodium Pyruvate and 0.1% Normacin,
Cultures were maintained in a humidified incubator at 36.7°C (5% CO2). Cells were
detached from cell culture flask by use of Trypsin EDTA.
Plating α-cells
For imaging experiments, cells were plated in glass bottom culture dishes 35/12
mm (Warner Instruments, Cat 64-0757) or in plastic dishes on micro cover glass (VWR
Scientific Inc, Cat 48366 067). Cover glass had been pretreated with either Poly-L
Lysine or with Polyethylenimine (PEI). Cells were imaged on day two and three after
plating cells.
Fura-2 AM Loading
Cells were loaded with the ratiometric dye Fura-2 AM (5 µM ) for 30 minutes at
room temperature while protected from light. Fura data are expressed in ratios of 380/340
image. Data were normalized to initial values to allow for comparison between the two
imaging systems used. All reported fura ratio values are at least 2-fold below saturation
as assessed with saturating Ca2+ levels induced by ionomycin.
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External solutions contained varying amounts of potassium, sodium and glucose
ranging from 2 mM K+ to 60 mM K+ and 0 mM glucose to 15 mM glucose. External
solutions contained 1 mM MgCl2, 10 mM HEPES (adjusted to pH 7.2) , 5 mM CaCl2,
and 2 mM KCl with 140 NaCl or 60 KCl with 82 mM NaCl (60 mM K+ solution). Dglucose was present at 2, 8, or 15 mM. Zero Ca2+ solution contained 1 mM EGTA and
no CaCl2.
Bath Perfusion Experiments
Cells were visualized with a Zeiss AxioVert S100, with a 40x oil objective lense,
images were captured using a Cooke SensiCam CCD Camera (PCO Imaging). The
microscope contained 10% transmittance neutral density filters. Images were acquired
and analyzed using Slidebook software, exposure times for 340 nm and 380 nm of light
were 25 ms and images were binned 4x4. Intermittent perfusion was performed during
imaging using a gravity flow system. Suction was set up on one side of the dish, while
inflow was set up on the opposite side. In flow ranged from 0.5 ml per minute to 1 ml
per minute. At specific time points valves to solutions were opened and drained for a set
amount of time. When small amounts of solutions were used the solution was pushed
slowly through the tubing with a syringe. At the end of each experiment solution was
changed to a 60 mM K+ solution in order to check cell function.
Puffing Experiments
Cells were visualized with a Olympus 1X71, with a 40x air objective lens. The
microscope contained 25% transmittance filters. Images were captured using a Hamatsu
Orca camera. Images were acquired and analyzed using Slidebook software, exposure
times for 340 nm and 380 nm of light were 50 ms and images were binned 8x8. Drugs
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were applied to clusters of cells using PicoSpritzer® II (Parker Hannifin Corporation) for
5 seconds. Following the experiment a visual check was made to make sure the pipette
tip did not move or break during the experiment.
Membrane Potential Experiments
The slow response molecular probe Bisoxonol reports large changes in membrane
potential. Bisoxonol is a lipophilic anion that increases fluorescence with depolarization,
while hyperpolarization leads to a decrease in fluorescence. αTC cells were loaded with
30 nM Bisoxonol for 20 minutes prior to imaging to allow the Bisoxonol to equilibrate.
Bisoxonol was present in all solutions during imaging at 30 nM concentration.
Cells were visualized with an Zeiss AxioVert S100, with a 40x oil objective lens,
images were captured using a Cooke SensiCam CCD Camera (PCO Imaging). The
microscope contained 10% transmittance filters. Images were acquired and analyzed
using Slidebook, exposure times for 480 nm excitation light were 3 ms and images were
binned 2×2. Images were acquired at five-second intervals. Constant perfusion was
performed during imaging. Suction was set up on one side of the dish, while inflow was
set up on the opposite side. Constant perfusion was performed because this is not a
ratiometric dye and is therefore sensitive to focal change. Bath solution changes were
made with gravity flow system. At specific times valves to solutions were opened and 15
seconds later the original open valve was closed.
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Ethanol Control
An ethanol control was performed in order to ensure that ethanol had no effect on
α-cells. 0.5 % ethanol was added to bath solution and 60 mM K+ was applied to the cells
using PicoSpritzer® II (Parker Hannifin Corporation) for 5 seconds. Lower starting
concentrations of Ca2+ were observed. Stock solutions were made more concentrated in
order to bypass any effects of ethanol.
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Table One: Drugs used During Experiments
Information pertaining to different drugs used during experimental procedures. Brief
descriptions of drug function, procedural concentrations, stock concentrations and solvent
used for the stock solution. For drugs dissolved in DMSO the dilution to the procedural
concentration is included in order to ensure a low percent of DMSO in the final solution.
Name
Function
Procedural
Stock
Stock
Concentration Concentration Solvent
Forskolin
Activates Adenyalte
50 µM
10 mM
DMSO
Cyclase, raises levels
(1:200)
of cAMP
IBMX
Inhibits PDE, keeps
1 µM
500 mM
DMSO
cAMP high
(1:500)
RpCamps
PKA inhibitor, NOT
11 µM
22 mM
Water
EPAC
Tolbutamide
Potassium channel
100 µM
Ranged from
Water
blocker
99.85-106 mM
8 Br-cAMP
Membrane permeable 2.3 mM
233 mM
Water
cAMP
PMA
Activates protein
100 nM
3.24 mM
kinase C
Nifedipine
Blocks L-type calcium 5 µM or 10µM 2.28 mM
Ethanol
channels
Conotoxin
N-type calcium
1µM
228 mM
Water
channel blocker
Diazoxide
Opens voltage-gated
530 µM or
265 mM
Ethanol
potassium channel
106 µM
8-CPT-2’-O- Me
EPAC activator
50 µM
50 mM
Water
cAMP
20 µM
6-Bnz cAMP
PKA activator
20 µM
10 mM
Water
Caffeine
Opens Ryanodine
1 mM
10 mM
Water
Receptors
Ryanodine
[nM] Holds channel
100 µM
10 mM
Water
half open.
[µM] Closes
ryanodine receptor
Rp-MB-cAMPs, Na Competitivie inhibitor 110 µM
5 mM
Water
of PKA types I and II
Fura-2 AM
Calcium indicator dye 5 µM
1 mM
DMSO
(1:200)
Ionomycin
Raises intracellular
DMSO
calcium
H89
Inhibits PKA
48 µM
9.6 mM
Water
DDA
Blocks Clyclases
50 µM
8.5 mM
Water
Bis-oxonol
Measures membrane
30 nM
300 µM
DMSO
potential
(1:1000)
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Table Two: Abbreviated Nomenclature
Abbreviated nomenclature for various drugs used during experiments.
Name
7β-Acetoxy-8,13-epoxy-1α,6β,9α-trihydroxylabd14-en-11-one
3-Isobutyl-1-methylxanthine
Rp-cAMPs
1-Butyl-3-(4-methylphenylsulfonyl)urea
8-Bromoadenosine-3′,5′-cyclic
monophosphorothioate, Rp-isomer
Phorbol 12-myristate 13-acetate
4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5pyridinedicarboxylic acid dimethyl ester
ω-conotoxin
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1dioxide
8-(4-Chlorophenylthio)-2'-O-methyladenosine3',5'-cycli c monophosphate sodium salt
N6-Benzoyladenosine-3′,5′-cyclic monophosphate
sodium salt
1,3,7-Trimethylxanthine
Ryanodine
Adenosine 3′,5′-cyclic Monophosphorothioate, 2′O-Monobutyryl-, Rp-Isomer, Sodium Salt

Abbreviation
Forskolin

Ryanodol 3-(1H-pyrrole-2-carboxylate)

Fura-2 AM
Invitrogen
Ionomycin
H89
DDA
Bis-oxonol
Molecular Probes, B438
PEI

Ionomycin calcium salt
H89 Dihydrochloride
2,5 Dideoxyadenosine
(DiBAC4(3))
Polyethyleneimine
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IBMX
RpCamps
Tolbutamide
8 Br-cAMP
PMA
Nifedipine
Conotoxin
Diazoxide
8-CPT-2’-O-Me cAMP
Biolog
6-Bnz cAMP
Calbiotech
Caffeine
Ryanodine
Rp-MB- camps, Na
Calbiotech

Results
Comparison of Pancreatic α-Cell Lines
Studies of alpha cell signaling can be simplified by monitoring activity in the
absence of paracrine factors. This requires a pure cell population such as can be obtained
with clonal cell lines. Currently there are two related mouse α-cell lines (αTC1-6 and
αTC1-9) primarily used in research. Gene expression studies in the lab have indicated
that these cells differ with respect to MC4R expression and adenylyl cyclase and PDE
isoforms (Lumsden MS thesis, 2008; E. Joachim unpublished). My first experiments
assessed whether differences also exist in the way these cells respond to stimulation.
When both cell lines were stimulated with varying amounts of glucose, changes in
intracellular calcium were recorded.
Figure 3 shows the effects of changing glucose concentrations on intracellular
calcium concentrations in the two α-cell lines. When αTC1-6 cells were changed from a
2 mM glucose solution to an 8 mM glucose solution, intracellular calcium concentration
decreased when these cells were perfused with a 15 mM solution, intracellular Ca2+
concentrations began to increase. The response in αTC1-9 cells did not parallel the
response in αTC1-6 cells. No changes in calcium concentration were observed when
cells were taken from 2 mM glucose to 8 mM glucose, and minimal increases were
observed when αTC1-9 cells were incubated in 15 mM glucose. Initially the cells were
bathed in 2 mM K+, 2 mM glucose external solution for 30 minutes. After 100 seconds
of imaging the external solution was changed to 2 mM K+, 8 mM glucose external
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solution. At 250 seconds after the beginning of imaging, external solution was changed
to 2 mM K+, 15 mM glucose external solution. A final solution change occurred at 500
seconds when the solution was changed to 60 mM K+, 2 mM glucose to depolarize the
cells. Both cell lines were treated under the same conditions.
All subsequent experiments were carried out in αTC1-6 cells. Glucose
concentrations were varied as indicated, however 8 mM glucose, which reflects normal
resting glucose in vivo was the standard condition.
High glucose concentrations close the KATP channel in β-cells, leading to an
overall membrane depolarization. α-Cells have the same KATP channel and L-type
calcium channel, but possess an N-type calcium channel and sodium channel. In order to
assess KATP channel influence on Ca2+ influx, KATP channels were held closed with
tolbutamide and open with diazoxide.
KATP channels effects on pancreatic α-cells
Potassium channels were pharmacologically blocked in α-cells to determine role
of potassium channels in calcium influx in α-cells. A comparison was made between the
effects of tolbutamide (a KATP channel inhibitor) in 2 mM glucose and 8 mM glucose in
αTC1-6 cells (Figure 4). Tolbutamide had little effect on intracellular calcium
concentrations in 2 mM glucose. In 8 mM glucose, calcium concentrations increased
after the addition of tolbutamide as seen in Figure 4 C and D. Addition of Diazoxide, a
compound that opens KATP channels, caused an increase in Ca2+ concentrations in α-cells
in 8 mM glucose (Figure 5). This increase is not what would be expected, which could
possibly be caused by the activation of N-type calcium channels.
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There were several possibilities of calcium channels involvement in Ca2+ influx.
The next experiments were aimed at determining which calcium channels were opened
when α-cells underwent strong, rapid depolarization.
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Figure 3: Comparison of αTC1-6 and αTC1-9 cell lines calcium influx in response to
varying glucose concentrations. Panel A shows αTC1-6 average trace with error bars,
panel B shows αTC1-9 average trace with error bars.
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Figure 4: Comparison of effects of Tolbutamide in 2 mM glucose and 8 mM glucose.
Cells in panels A and B are in 2 mM K+, 2 mM glucose external solution. At 317
seconds external solution containing Tolbutamide [100 µM] was perfused into the bath.
At 530 seconds external solution was changed to one containing 60 mM K+, 2 mM
glucose. In panels C and D cells were in 2 mM K+, 8 mM glucose external solution. At
300 seconds external solution was changed to 2 mM K+, 8 mM glucose external solution
containing Tolbutamide [100 µM]. At 530 seconds external solution was changed to one
containing 60 mM K+, 8 mM glucose.
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Figure 5: Diazoxide effect of αTC1-6 cells in 8 mM glucose. Panel A shows all traces
of all cells within the dish. Panel B shows the average trace with error bars of all the
cells.
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Calcium channel activation during stimulation of α-cells with 60 mM K+ in 8 mM
glucose
Alpha cells were stimulated with five-second puffs of 60 mM K+. Figure 6 shows
the calcium concentrations changes due to membrane depolarization. The first pulse of
potassium resulted in the highest calcium influx. Subsequent pulses decreased in
intensity. After four stimulatory puffs of high potassium solution, calcium concentrations
started to increase without stimulation, possibly due to calcium-induced calcium release.
In order to determine which types of calcium channels were involved in the calcium
influx different channel blockers were applied to the cells prior to stimulation with 60
mM K+.
Treatment with the L-type Ca2+ channel blocker, nifedipine [10 µM], resulted in a
block of calcium response from the high potassium stimulation. Several experiments
were conducted on different days in order to ensure that intracellular calcium
concentrations were prevented from increasing in the presence of nifedipine when
stimulated with high concentrations of external potassium.
Treatment with the N-type Ca2+ channel blocker, ω-conotoxin [1 µM], did not
result in a complete block of Ca2+ influx but did affect the calcium response. Calcium
influx was limited by the third stimulatory puff of high external potassium (Fig 6 c).
After several experiments of observing the effects of ω-conotoxin different responses
were observed. The average trace shows that stimulation with high external potassium
causes an increase in Ca2+ concentrations. The various effects of ω-contoxin are shown
in figure seven. In some instances no increase in Ca2+ concentrations were observed,
while in other instances large increases in the concentration of Ca2+ were observed.
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Figure 6: Effects of Membrane Depolarization on Ca2+ Levels
Cells were loaded with Fura-2 AM in 2 mM K+, 8 mM glucose external solution.
Five-second application of 60 mM K+ are represented by arrows in the above panels.
Puffs were made every minute for six minutes. Panel A shows the average trace of 60
mM K+ puffs without the presence of any inhibitory drugs. Panel B shows the average
trace of 60 mM K+ in the presence nifedipine [10 µM]. Panel C shows the average trace
of 60 mM K+ in the presence of ω-conotoxin [1 µM].
In euglycemic conditions L-type calcium channels open in response to membrane
depolarization, while N-type calcium channels are near the threshold of inactivation. In
type-1 diabetes the quantity of β-cells decreases, which creates overall higher blood
glucose levels. In higher levels of plasma glucose α-cell function could be altered. In
order to determine how α-cell function differs in higher glucose, the same experiment
was done in the presence of 15 mM glucose.
Calcium channel involvement during stimulation of α-cells with 60 mM K+ in 15
mM glucose
Alpha cells were stimulated with five-second puffs of 60 mM K+. Figure 8 shows
the calcium concentration changes due to depolarization in high glucose. The first pulse
of potassium resulted in the highest calcium influx. Subsequent pulses decreased in
intensity.
Treatment with the L-type Ca2+ channel blocker, nifedipine, resulted in a partial
block of response from the high potassium stimulation. Treatment with the N-type Ca2+
channel blocker, ω-conotoxin, also resulted in a partial block of Ca2+ influx. When
stimulated in the presence of both toxins, residual calcium influx occurred, suggesting the
presence of R-type current.
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Figure Seven: Average and individual traces of 60 mM K+ application in the presence of
ω-conotoxin.
Panel A shows the average trace with error bars in response to 60 mM K+
application in 8 mM glucose. Panels B through D show different types of responses to 60
mM K+ application in the presence of ω-conotoxin [1 µM] in 8 mM glucose.
Puffing and Perfusion of Forskolin
Epinephrine and αMSH are known to activate Gαs, leading to stimulation of
adenylyl cyclase creating cAMP. Since only the pathway of cAMP was of interest
pharmacological agents could be used to create intracellular cAMP. 8 Br-cAMP [2.3
mM] was applied to α-cells in order to observe α-cell response to cAMP (data not
shown). Minimal Ca2+ influx was observed from application of 8 Br-cAMP. Since 8 BrcAMP is not very membrane permeable, the pharmacological andenylyl cyclase activator,
forskolin was applied to increase intracellular concentrations of cAMP.
Alpha cells stimulated with a five-second puff of the adenylyl cyclase activator
forskolin [50 µM] respond with increasing Ca2+ concentrations (Figure 9). Similarly
when α-cells were stimulated with forskolin for prolonged periods of time, they also have
an increase in Ca2+ concentrations. A five-second puff of forskolin is likely more similar
to a physiological stimulus because adenylate cyclase is not continuously stimulated.
Forskolin Response After Removing Calcium
Perfusion and brief application of forskolin both lead to an increase in
intracellular Ca2+. The Ca2+ influx is a slow response that looks similar to calciuminduced calcium release. In order to determine if this influx is calcium-induced calcium
release, calcium was removed from the extracellular solutions, which would indicate any
Ca2+ increase was due to internal store release.
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Figure Eight: Potassium application in 15 mM Glucose.
Cells were loaded with Fura-2 AM in 2 mM K+, 15 mM glucose external solution.
5-second puffs of 60 mM K+ are represented by arrows in the above panels. Puffs were
made every minute for six minutes. Panel A shows the average trace of 60 mM K+ puffs
without the presence of any inhibitory drugs. Panel B shows the average trace of 60 mM
K+ in the presence of ω-conotoxin [1 µM]. Panel C shows the average trace of 60 mM
K+ in the presence nifedipine [10 µM]. Panel D shows the average trace of 60 mM K+ in
the presence of ω-Conotoxin and Nifedipine.
Figure 10 shows a strong depolarization from 60 mM K+, from a perfusion
experiment in the presence of calcium. Membrane depolarization causes an increase in
calcium concentration. When αTC1-6 cells are stimulated with forskolin [50 µM] in the
presence of calcium and then calcium is removed after the response begins, the calcium
concentration continues to increase suggesting store release. Note that a subsequent 60
mM K+ stimulation with calcium in the external solution now gives only a weak
response.
Before Ca2+ is removed from solution Ca2+ enters the cell through voltage-gated
Ca2+ channels, followed by store release. Stimulation of α-cells with 60 mM K+ in 8 mM
glucose led to Ca2+ influx through L-type Ca2+ channels. Ca2+ influx after stimulation
with forskolin led to influx through Ca2+ channels. The next set of experiments will
determine which Ca2+ channels are involved in this influx.
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Figure 9: Perfusion and Picosprtizing Forskolin on αTC1-6 cells
Panel A shows a five-second stimulation of α-cells with forskolin [50 µM]. Panel
B shows a bath perfusion experiment using forskolin [50 µM].
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In response to forskolin calcium concentrations increased even in the presence of ωconotoxin. The increase was similar to the increase following forskolin alone. The
calcium concentration increase was completely inhibited by the presence of nifedipine
[20 µM]. After stimulation with forskolin, there was no apparent change in calcium
concentrations, indicating L-type Ca2+ channel involvement. The specific cAMP
pathway that led to the opening of the L-type channel is not specified by this experiment.
In order to determine the specific method of activation further experiments were
performed.
Calcium Channel Participation after Forskolin Stimulation
During a five-second stimulation with forskolin [50 µM], αTC1-6 cells had a
gradual increase in calcium concentration. In order to determine what calcium channels
are involved in the increase in calcium concentration, calcium channel blockers were
applied prior to stimulation with forskolin. As shown in Figure 11 (panels B and C),
calcium current blockers nifedipine [10 µM] or ω-conotoxin [1 µM] were applied. In
response to forskolin calcium concentrations increased even in the presence of ωconotoxin. The increase was similar to the increase following forskolin alone. The
calcium concentration increase was completely inhibited by the presence of nifedipine
[20 µM]. After stimulation with forskolin, there was no apparent change in calcium
concentrations, indicating L-type Ca2+ channel involvement. The specific cAMP
pathway that led to the opening of the L-type channel is not specified by this experiment.
In order to determine the specific method of activation further experiments were
performed.
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Figure 10: Forskolin stimulation and transfer to zero calcium.
Cells were loaded with Fura-2 AM in 2 mM K+, 8 mM glucose external solution.
Panel A shows perfusion of 60 K+ at 300 seconds. Panel B shows perfusion of forskolin
[50 µM] at 200 seconds followed by perfusion of zero calcium and EGTA [0.5 mM]
external solution with forskolin at 320 seconds. Final solution change to 60 mM K+ was
made at 605 seconds.
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Figure 11: Forskolin application
blockers.
Panel A shows a 5-second application with forskolin [50 µM] in 8 mM glucose.
Panel B shows forskolin stimulation after treatment with ω-conotoxin [1 µM]. Panel C
shows forskolin stimulation after treatment with nifedipine [10 µM]. Arrows indicate
moment of forskolin application.
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Cyclic AMP Dependent Pathways in α-cells
As previously described, cAMP has several potential pathways that affect cellular
responses (Gromada et al, 2007). In order to establish the cAMP pathways activated, αcells were incubated with a membrane permeant cAMP analog that specifically activates
PKA or a membrane permeant cAMP analog that specifically activates EPAC. Figure 12
shows a 5-second stimulation with forskolin [50 µM], to increase cAMP levels (which
would activate both PKA and EPAC). Panel B shows the stimulation with an EPAC
analog (8-CPT-2’-O-Me) [20 µM]. A five-second stimulation causes a slow increase in
calcium concentration. Similarly stimulation with the PKA analog (6-Bnz- cAMP) [20
µM] causes a slow increase in Ca2+ concentrations. Both PKA and EPAC lead to Ca2+
influx within α-cells. Further experiments were performed to determine which Ca2+
channels led to the Ca2+ influx for both cAMP pathways.
Potential Pathways of EPAC within α-cells
Epac was shown to stimulate Ca2+ increase in α-cells. In order to determine if
EPAC has an effect on Ca2+ channels or store release, several channel blockers were
used. In the presence of the N-type calcium channel blocker, ω-conotoxin [1 µM],
calcium concentrations increased following application of forskolin [50 µM]. In the
presence of the L-type calcium channel blocker, nifedipine [10 µM], calcium
concentrations did not change following stimulation with forskolin [50 µM]. In order to
determine if Ca2+ increase from EPAC is dependent on the presence of extracellular Ca2+,
or if store release could be directly activated, Ca2+ was removed from the extracellular
solution. Prior to the five-second application of 8-CPT-2’-O-Me cAMP extracellular
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Figure 12: Potential pathways of cAMP
Panel A shows stimulation forskolin [50 µM] at the arrow for point of application.
Panel B shows stimulation with 8-CPT-2’-O-Me cAMP [20 µM], the arrow shows time
of five-second application. Panel C shows stimulation with 6-Bnz cAMP [20 µM], the
arrows show the time of five-second application.
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solution was switched to a solution without calcium and with EGTA [0.5 mM] present to
chelate Ca2+ ions. After stimulation of EPAC, no calcium response was observed.
Potential Pathways of PKA within α-cells
It is known that PKA phosphorylates channels as a method of regulation (Kang et
al, 2006). Since PKA was shown to stimulate calcium increase within α-cells, to
determine PKA’s effects on calcium channels, channel blockers were applied. In the
presence of the N-type Ca2+ channel blocker, ω-conotoxin [1 µM], calcium
concentrations increased. Compared to PKA activation in absence of ω-conotoxin,
calcium concentration influx is slightly decreased. The L-type calcium channel blocker,
nifedipine [10 µM], completely blocked calcium concentration increase. In order to
determine if calcium increase from PKA is dependent on the presence of extracellular
calcium, calcium was removed from the extracellular solution. Prior to the five-second
application of 6-Bnz-cAMP, extracellular solution was switched to a solution without
calcium and EGTA [0.5 mM] present in order to chelate calcium ions. After stimulation
of PKA, no calcium response was observed.
Both EPAC and PKA stimulation appeared to cause calcium-induced calcium
release. In order to determine the channels releasing Ca2+ from the endoplasmic
reticulum, ryanodine was used to block the ryanodine receptor.
Ryanodine Effects of cAMP Dependant Pathways
In β-cells calcium from the endoplasmic reticulum is mobilized from ryanodinesensitive receptors and IP3 receptors (Seino, 2005). Ryanodine at micromolar
concentrations blocks the ryanodine-sensitive receptor. Ryanodine was applied to α-cells
in order to determine if calcium released from the endoplasmic reticulum through
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Figure 13: Potential pathways of EPAC
Panel A shows the average trace after stimulation from EPAC analog, 8-CPT-2’O-Me cAMP [20 µM]. Panel B shows the average trace after stimulation from EPAC
analog in the presence of ω-conotoxin [1 µM]. Panel C shows the average trace after
stimulation from EPAC analog in the presence of nifedipine. Panel D shows stimulation
from EPAC analog in the absence of external calcium and presence of EGTA [0.5 mM].
Arrows indicate the time of application of EPAC analog.
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ryanodine-sensitive receptor. Stimulation of PKA caused an increase in calcium
concentration in α-cells. When ryanodine [100 µM] was applied to α-cells, calcium
concentration increase was not inhibited. When EPAC was applied to α-cells, an
increase in calcium concentration was also observed. After application of ryanodine,
cells still have an increase in Ca2+ concentrations. Pre-incubation in ryanodine [100 µM]
did not cause a block of calcium increase.
In order to ensure that the ryanodine was able to block the ryanodine receptor, it
was tested on skeletal muscle cells. Cultured muscle cells contracted in response to
electrical stimulation. Ryanodine blocked muscle contraction. This indicated that the
ryanodine was functional. (Data not shown).
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Figure 14: Potential pathways of Protein Kinase A
Panel A shows stimulation from PKA analog [20 µM]. Panel B shows
stimulation from PKA analog in the presence of ω-conotoxin [1 µM]. Panel C shows
stimulation from PKA analog in the presence of nifedipine [10 µM]. Panel D shows
stimulation from PKA analog in the absence of external calcium and presence of EGTA
[0.5 mM]. Arrows indicate moment of five-second application of PKA analog.
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Figure 15: Ryanodine Effects on cAMP Dependant Pathways
Panel A shows stimulation from PKA analog (6-Bnz cAMP) [20 µM]. Panel B
shows stimulation from PKA analog in the presence of ryanodine [100 µM]. Panel C
shows stimulation from EPAC analog (8-CPT-2’-O-Me cAMP) [20 µM]. Panel D shows
stimulation from EPAC analog in the presence of ryanodine [100 µM]. Arrows indicate
moment of five-second application of specified analog.
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Relative Changes in Membrane Potential
Observing changes in membrane potential would lead to further understanding of
Ca2+ influx in α-cells. EPAC or PKA stimulation within the cell could cause Ca2+
influxes to occur through membrane potential changes. In order to determine if the Ca2+
influx was due to a change in membrane potential bisoxonol was applied to α-cells.
Changes in glucose concentrations impacted Ca2+ influx in α-cells. The closure
of the KATP channel led to opening of voltage-gated Ca2+ channels. In order to observe
membrane potential changes in different glucose concentrations bisoxonol was applied to
α-cells.
αTC1-6 cells were equilibrated with bisoxonol and imaged. Cells were treated
with forskolin and for strong membrane depolarization. No change in fluorescence
occurred after the addition of forskolin. The slope of the average trace does not change
noticeably. When cells were exposed to different concentrations of glucose, a change in
fluorescence can be observed when glucose was changed from 8 mM to 15 mM. The
cells appear to depolarize when changing from 8 mM glucose to 15 mM glucose.
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Figure 16: Membrane potential changes measured by Bisoxonol
External solution containing bisoxonol [30 nM] and forskolin [50 µM] was added
at 100 seconds. External solution was changed to 60 mM K+ external solution at 475
seconds. Panel A shows individual traces. Panel B shows the average of the individual
traces.
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Figure 17: Effects of glucose concentration on membrane potential
Bisoxonol measurements of membrane potential with changes in glucose
concentrations. Panel A shows individual traces. Panel B shows the average of the
individual traces.
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Discussion
Glucose stimulation experiments in αTC1-9 and αTC1-6 cells suggest that a
difference exists between the cell lines. In αTC1-9 cells calcium concentrations do not
vary between 2 mM glucose and 8 mM glucose. A slight increase in calcium occurs
when glucose is raised to 15 mM. In αTC1-6 cells, calcium concentrations decrease
when the external solution is changed from 2 mM glucose to 8 mM glucose, suggesting
mild depolarization may cause inactivation of N-type calcium or Na+ channels. Stronger
depolarization occurs when the glucose concentration is switched from 8 mM to 15 mM
glucose. KATP channels are closing with the increase in glucose concentrations causing a
depolarization. Physiologically this creates a conundrum about α-cell stimulation. αCells should not depolarize in high glucose concentrations, since they release glucagon to
raise blood sugar. This suggests that paracrine or endocrine factors are stimulating or
inhibiting α-cells. This experiment also shows that 8 mM glucose is a good
concentration to use to study α-cells because α-cells Ca2+ is relatively stable, and more
importantly, this concentration of glucose would be a resting blood glucose level.
Tolbutamide was used to pharmacologically block KATP channels. In β-cells
tolbutamide causes depolarization and in turn an increase in intracellular calcium. αCells in 2 mM glucose show a lack of response to tolbutamide and a small response in 8
mM glucose (Figure 4). Differences in responses of α-cells and β-cells might be due to
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differences in KATP channel sensitivity. Differences might also exist between glucose
sensitivity between cell types.
When cells are treated diazoxide, KATP channels are held open, which should
cause the cells to hyperpolarize. A Ca2+ influx is witnessed after the application of
diazoxide in 8 mM glucose (Figure 5). It is likely that an initial hyperpolarization by
diazoxide relieves inactivation of Na+ channels and N-type channels. This could lead to
opening of these channels and a subsequent depolarization and Ca2+ influx. The
observation that subsequent high K+ does not lead to further Ca2+ suggests the cells were
strongly depolarized by that point.
Strong depolarizations can be produced in α-cells through high concentrations of
K+. Using a picospritzer to apply short puffs of solution allows for a closer to
physiological stimulation. Cells were stimulated with 60 mM K+ at one-minute intervals
(Figure 6). Under 8 mM glucose, depolarization produced a calcium influx and gradually
led to calcium-induced calcium release. When calcium channel blockers were added to
the solution, the cellular responses varied. Nifedipine blocks L-type calcium channels.
When nifedipine was applied to α-cells prior to puffs of 60 mM K+, the calcium increase
was inhibited, indicating that L-type calcium channels are necessary for Ca2+ influx in αcells in 8 mM glucose. Application of ω-conotoxin, used to block N-type Ca2+ channels,
did not have complete block of Ca2+ influx. Responses in the presence of ω-conotoxin
varied: one response to stimulation, cells would respond to all stimulations and
sometimes cells lack responses all together (Figure 7). This may reflect an intermediate
membrane potential in 8 mM glucose such that the degree of inactivation of N-type
channels was highly variable between cells.

48

In 15 mM glucose α-cells respond differently to stimulation of high K+ (Figure
8). The addition of ω-conotoxin, there is a definite decrease in the Ca2+ concentration
response due to stimulation, indicating that N-type calcium channels play a role in Ca2+
influx. Nifedipine has a similar response in 15 mM glucose, presenting only a partial
block of the 60 mM K+ response. With the addition of both ω-conotoxin and nifedipine
together a small Ca2+ influx still exists. Since both N- and L-type Ca2+ channels are
blocked, another channel is involved in the Ca2+ influx. R-type Ca2+ channels participate
in this depolarization. Traditionally, R-type Ca2+ channels are resistant to the calcium
channel blockers nifedipine and ω-conotoxin. The role of R-type calcium channels in
hyperglycemic becomes apparent because Ca2+ influx is still observed in the presence of
channel blockers. These channels participate very minimally, if at all, in 8 mM glucose,
which can be demonstrated by the ability of nifedipine to completely block Ca2+
responses. The mechanism by which high glucose makes R-type channels available is not
known.
Cyclic AMP Effects in α-cells
Forskolin is stimulates adenylate cyclase and leads to an increase in cAMP.
When forskolin is applied to α-cells through a five-second puff, it causes an increase in
Ca2+ concentrations (Figure 9).
In αTC1-9 cells, a rise in intracellular Ca2+ was not consistently obtained. To
obtain a Ca2+ influx from cAMP during perfusion, a combination of forskolin and IBMX
must be used (data not shown). IBMX inhibits phosphodiesterase (PDE), preventing the
degradation of cAMP, and this causes extremely high levels of cAMP within the cells.
αTC1-6 cells do not require PDE inhibition to provide an increase in Ca2+ concentrations.
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When αTC1-6 cells are stimulated by perfusion with forskolin in the presence of
Ca2+ and then Ca2+ is removed, an increase in intracellular Ca2+ is still observed, which
suggests that cAMP is causing Ca2+ induced Ca2+ release (CICR) (Figure 10). CIRC
requires and initial influx of Ca2+ to occur.
Forskolin causes an increase in Ca2+ concentration. In order to determine the
channels playing a role in the Ca2+ increase, Ca2+ channel blockers were applied (Figure
11). Addition of ω-conotoxin did not cause a block in Ca2+ increase, indicating that Ntype Ca2+ channels are not being affected by cAMP. Addition of nifedipine shows a
block of Ca2+ influx, providing evidence that L-type Ca2+ channels are impacted by
cAMP.
In order to further characterize the pathway of cAMP two targets of cAMP can
be analyzed. One possibility to determine PKA functions would be to block PKA.
Preliminary attempts were made to block the actions of PKA by use of Rp-cAMPs with
stimulation from α-MSH. Rp-cAMPs did not have high membrane permeability and did
not seem to have an effect on α-cell function (unpublished data from Liang Liang). Use
of Rp-MB-cAMPs, is a more membrane permeable compound. Some increase in Ca2+
still occurs after application with Rp-MB-cAMPs Na+, which indicates another pathway
other than PKA exists in Ca2+ influx or that inhibition of PKA was incomplete. Both
versions of Rp-cAMPs are ~50-fold less membrane permeant than the cAMP analogs that
stimulated PKA or EPAC.
To determine the role of PKA in α-cells, the ser/thr kinase inhibitor H89 was
used. H89, a known inhibitor of PKA, was applied to αTC1-9 cells and a variation of
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responses occurred (data not shown). However, it was concluded that H89 was having
nonspecific effects on depolarization induced Ca2+ influx.
Specific activators for PKA and EPAC exist and can be used to determine how
cAMP functions in α-cells. By comparing the Ca2+ response of forskolin to individual
responses of stimulated EPAC and PKA, allowed for further characterization of α-cell
pathways (Figure 12). 8-CPT-2’-O-Me cAMP (EPAC analog) stimulates Ca2+ increases
in αTC1-6 cells, and 6-Bnz cAMP (PKA analog) also stimulates Ca2+ increase in αTC1-6
cells. After determining that cAMP uses both EPAC and PKA in Ca2+ influx, further
investigations can determine the specific targets of both in α-cells.
To determine EPACs targets within α-cells combinations with ω-conotoxin and
nifedipine allowed for a more in depth analysis (Figure 13). When 8-CPT-2’-O-Me
cAMP was applied in the presence of ω-conotoxin, Ca2+ influx was not inhibited. Thus,
N-type Ca2+ channels are not stimulated by EPAC in α-cells. Application of nifedipine
prior to stimulation with 8-CPT-2’-O-Me cAMP blocks Ca2+ influx, suggesting that
L-type channels interact with EPAC. Stimulation with 8-CPT-2’-O-Me cAMP in zero
Ca2+ and in the presence the Ca2+ cheltor EGTA, resulted in a reduced Ca2+ influx, which
indicates that Ca2+ influx is required in order to have Ca2+ release from stores.
Similar experiments were done to determine the pathway of PKA in α-cells by
using ω-conotoxin and nifedipine (Figure 14). A five-second pulse of 6-Bnz cAMP
applied in the presence of ω-conotoxin, resulted in only a slight decrease in Ca2+ influx.
This suggests that N-type channels are potentially a target for PKA in α-cells. Nifedipine
completely blocked Ca2+ influx from stimulation of 6-Bnz cAMP. This block indicates
L-type channels interact with PKA to induce an increase in Ca2+ in α-cells. Additionally,
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stimulation with 6-Bnz cAMP in 0 Ca2+ in the presence of EGTA prevented Ca2+ influx.
Showing that Ca2+ influx is necessary in order to have Ca2+ store release.
Potential Role of Ryanodine
Ryanodine receptors are activated in the presence of caffeine. α-cells were treated
with caffeine to determine if ryanodine receptors play a role in Ca2+ release from
intracellular stores. When caffeine alone was applied to α-cells, there was no immediate
increase in Ca2+ concentration (data not shown). When cells were stimulated with 60 mM
K+ in the presence of caffeine, a slight increase in Ca2+ was noticed compared to control
conditions. Ryanodine receptors would also have been open before stimulation in the
presence of caffeine and would have ideally shown an increase in Ca2+ concentrations.
The increased response may be due to some opening of ryanodine receptors.
In order to determine the pathway in which EPAC and PKA are causing store
release, ryanodine was used. At micromolar concentrations ryanodine will close the
ryanodine-sensitive receptor, preventing Ca2+ release from stores. Ryanodine was
applied to cells before imaging started (Figure 15). When cells were incubated in
ryanodine, there was no difference in Ca2+ influx (data not shown). When α-cells were
stimulated with 8-CPT-2’-O-Me cAMP in the presence of ryanodine; there was no block
of Ca2+ concentration increase. Similar results occurred with the application of 6-Bnz
cAMP in the presence of ryanodine, there was no apparent change in Ca2+ concentration
increase. In order to ensure that store release is not coming from the ryanodine-sensitive
receptor, the quality of the ryanodine had to be determined. Muscle cells depend on
calcium store release in order to contract. Electrical stimulation of muscle cells results in
muscle contraction. Ryanodine applied at the same concentration used in the α-cell
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experiments, was applied to muscle cells. Complete block of muscle contraction upon
stimulation confirmed that the ryanodine was functional. Thus, EPAC and PKA do not
cause Ca2+ increases by release through ryanodine-sensitive channels in α-cells. The
most likely pathway of this Ca2+ release is therefore through IP3 receptor in both EPAC
and PKA pathways.
Lastly bisoxonol was used to evaluate changes in membrane potential. Addition
of forskolin to α-cells caused a small depolarization. This indicates that cAMP is has an
effect on membrane potential. Interestingly addition of α-MSH causes the membrane to
hyperpolarize (data not shown). Since α-MSH causes an increase in cAMP, one would
expect a similar reaction.
Changing glucose concentrations also had an effect on membrane potential
(Figure 17). By looking at the graph it is indicated that as glucose concentrations
increase the membrane becomes slightly more depolarized. More KATP channels close
with increased glucose concentrations. As more ATP is produced in the cell more
channels will be shut down leading to more membrane depolarization. Bisoxonol only
gives general information on membrane potential and does not allow determination of
specific membrane potentials. In order to precisely determine membrane potentials patch
clamp recordings would have to be taken.
Protein kinase C/PMA
PMA [100 nM] was used to test the role of protein kinase C (PKC) in α-cells after
stimulation by 60 mM K+ (data not shown). When bath solution was changed to 60 mM
K+ in the presence of PMA and was again changed to a 2 mM K+ solution calciuminduced calcium release took place. The activation of PKC increased the cells likelihood
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of having calcium-induced calcium release. In order to fully understand the mechanisms
in which PKC is causing this increase in Ca2+, further research would need to done to
determine the specific targets of PKC in α-cells.
Future Directions
These experiments answered many questions, while opening the door to many
other questions. Glucose concentrations were shown to affect Ca2+ influx in α-cells. In
order to know what Ca2+ currents are affected from the changes in glucose, patch clamp
recordings could be performed to determine the exact channels involved. Patch clamp
recording would also give a more accurate picture of membrane potential changes with
changing glucose concentrations.
The ryanodine receptor does appear to be involved in Ca2+ store in α-cells, which
is somewhat surprising. No good IP3 blockers exist, so determining its function would be
more complicated. Knocking out transcripts leading to the formation of the IP3 receptor
would allow for a study of its function in α-cells. Small interfering RNA could be used
to knock the production of the IP3 receptor. By knocking out this transcript in a α-cell
line, one could determine if the IP3 receptor leads to intracellular Ca2+ store release.
Determining the way α-cells functions ultimately leads to a bigger picture
understanding of glucose homeostasis. In type-1 diabetes, β-cell function is untimely
lost, leading to higher plasma glucose levels. Observing that α-cells are stimulated in
high glucose leads to the conclusion that α-cells are causing additional increases in
plasma glucose levels. Pharmacological agents can be produced to specifically target
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α-cell function to help manage glucose increases within the body. Knowing pathways
within α-cells that lead to increases in Ca2+ can help determine ways to regulate these
cells.
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